Award tenders
Awarded contractOpenSuppliesPoland

Sukcesywne dostawy produktów farmaceutycznych dla Szpitali Pomorskich Sp. z o.o. - produkty farmaceutyczne – programy lekowe 2026v62

10 suppliers awarded16 lots awarded€2.33M awarded

Buyer: Szpitale Pomorskie Sp. z o.o. / Gdynia, Poland

Published Jul 14, 2026Awarded May 31, 2026
Pharmaceutical productsAntineoplastic and immunomodulating agents

Awarded value

€2.33M

Estimated value

€2.33M

Awarded at 100% of estimated value

Award date

May 31, 2026

Winners

10

Lots awarded

16

Award values

Notice total

€2.33M

Sum of lot awards

€2.31M

TED notice total and lot-level values do not exactly match.

Winners

AMGEN SP. Z O.O.

Warszawa, POL

4 lots

€836,065 This contract

22 award notices38 awarded lots€27.54M total

2 lots

€546,556 This contract

27 award notices46 awarded lots€59.16M total

ABBVIE Sp. z o.o.

Warszawa, POL

1 lot

€268,922 This contract

9 award notices20 awarded lots€13.25M total

1 lot

€148,595 This contract

127 award notices182 awarded lots€41.31M total

€111,078 This contract

10 award notices10 awarded lots€526,882 total

1 lot

€104,229 This contract

2 award notices2 awarded lots€873,788 total

Tramco Sp z o. o.

Płochocin, POL

1 lot

€82,243 This contract

41 award notices128 awarded lots€13.36M total

Astrazeneca Kft.

Budapeszt, HUN

2 lots

€41,931 This contract

92 award notices122 awarded lots€54.70M total

Sanofi Sp. z o.o.

Warszawa, POL

1 lot

€27,332 This contract

21 award notices38 awarded lots€13.34M total

Urtica Sp. z o.o.

Wrocław, POL

1 lot

€3,726 This contract

123 award notices299 awarded lots€230.18M total

Lots awarded

LotTitleWinnerAward valueMain CPV
LOT-0049
AMGEN SP. Z O.O.€675,059

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0051
Roche Polska Sp. z o.o.€518,452

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0050
ABBVIE Sp. z o.o.€268,922

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0053
Takeda Pharma Sp. z o.o.€148,595

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0062
Not specified€140,516

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0059
Centrala Farmaceutyczna Cefarm SA€111,078

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0047
NEUCA SPÓŁKA AKCYJNA€104,229

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0054
AMGEN SP. Z O.O.€82,243

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0055
Tramco Sp z o. o.€82,243

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0058
AMGEN SP. Z O.O.€54,266

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0052
Astrazeneca Kft.€38,097

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0060
Roche Polska Sp. z o.o.€28,104

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0046
Sanofi Sp. z o.o.€27,332

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0061
AMGEN SP. Z O.O.€24,497

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0048
Astrazeneca Kft.€3,834

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)

LOT-0056
Urtica Sp. z o.o.€3,726

Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)